Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules

Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase...

Full description

Bibliographic Details
Main Authors: Yu, Yu, Gaillard, S., Phillip, J., Huang, T., Pinto, S., Tessarollo, N., Zhang, Z., Pandey, A., Wirtz, D., Ayhan, A., Davidson, B., Wang, T., Shih, I.
Format: Journal Article
Published: 2015
Online Access:http://hdl.handle.net/20.500.11937/21755
_version_ 1848750678888939520
author Yu, Yu
Gaillard, S.
Phillip, J.
Huang, T.
Pinto, S.
Tessarollo, N.
Zhang, Z.
Pandey, A.
Wirtz, D.
Ayhan, A.
Davidson, B.
Wang, T.
Shih, I.
author_facet Yu, Yu
Gaillard, S.
Phillip, J.
Huang, T.
Pinto, S.
Tessarollo, N.
Zhang, Z.
Pandey, A.
Wirtz, D.
Ayhan, A.
Davidson, B.
Wang, T.
Shih, I.
author_sort Yu, Yu
building Curtin Institutional Repository
collection Online Access
description Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase (SYK) and phospho-SYK. Invitro, paclitaxel-resistant cells expressed higher SYK, and the ratio of phospho-SYK/SYK positively associated with paclitaxel resistance in ovarian cancer cells. Inactivation of SYK by inhibitors or gene knockdown sensitized paclitaxel cytotoxicity invitro and invivo. Analysis of the phosphotyrosine proteome in paclitaxel-resistant tumor cells revealed that SYK phosphorylates tubulins and microtubule-associated proteins. Inhibition of SYK enhanced microtubule stability in paclitaxel-resistant tumor cells that were otherwise insensitive. Thus, targeting SYK pathway is a promising strategy to enhance paclitaxel response.
first_indexed 2025-11-14T07:40:39Z
format Journal Article
id curtin-20.500.11937-21755
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:40:39Z
publishDate 2015
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-217552017-09-13T13:54:25Z Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules Yu, Yu Gaillard, S. Phillip, J. Huang, T. Pinto, S. Tessarollo, N. Zhang, Z. Pandey, A. Wirtz, D. Ayhan, A. Davidson, B. Wang, T. Shih, I. Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase (SYK) and phospho-SYK. Invitro, paclitaxel-resistant cells expressed higher SYK, and the ratio of phospho-SYK/SYK positively associated with paclitaxel resistance in ovarian cancer cells. Inactivation of SYK by inhibitors or gene knockdown sensitized paclitaxel cytotoxicity invitro and invivo. Analysis of the phosphotyrosine proteome in paclitaxel-resistant tumor cells revealed that SYK phosphorylates tubulins and microtubule-associated proteins. Inhibition of SYK enhanced microtubule stability in paclitaxel-resistant tumor cells that were otherwise insensitive. Thus, targeting SYK pathway is a promising strategy to enhance paclitaxel response. 2015 Journal Article http://hdl.handle.net/20.500.11937/21755 10.1016/j.ccell.2015.05.009 unknown
spellingShingle Yu, Yu
Gaillard, S.
Phillip, J.
Huang, T.
Pinto, S.
Tessarollo, N.
Zhang, Z.
Pandey, A.
Wirtz, D.
Ayhan, A.
Davidson, B.
Wang, T.
Shih, I.
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
title Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
title_full Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
title_fullStr Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
title_full_unstemmed Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
title_short Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
title_sort inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules
url http://hdl.handle.net/20.500.11937/21755